Outstanding phenotypic differences in the profile of amyloid-β between Tg2576 and APPswe/PS1dE9 transgenic mouse models of Alzheimer’s disease
Manuscript Number:
16-0280R1
Author(s):
José Antonio Allué, Noelia Fandos, María Izco, Samuel Ogueta, María Pascual-Lucas, Pedro Pesini, Virginia Pérez-Grijalba, Leticia Sarasa, Manuel Sarasa
Disclosures
José Antonio Allué
Nothing to Disclose
Noelia Fandos
Nothing to Disclose
María Izco
Nothing to Disclose
Samuel Ogueta
Nothing to Disclose
María Pascual-Lucas
Nothing to Disclose
Virginia Pérez-Grijalba
Nothing to Disclose
Pedro Pesini
Sponsors:
Director R&D
Manuel Sarasa
Equity:
I am the scientific founder (2004) and one of the current shareholders of Araclon Biotech Ltd.
Sponsors:
President, CEO and CSO of Araclon Biotech Ltd.
Patents/Royalties
I have invented patents related to Alzheimer's disease diagnosis and treatment with Araclon Biotech Ltd.